Clinical meaning
Inhaled corticosteroids (ICS) are the cornerstone of persistent asthma management and play an important role in COPD treatment when combined with long-acting bronchodilators. Understanding their mechanism, device-specific pharmacokinetics, and clinical application is essential for NP prescribing.
ICS exert their anti-inflammatory effect by crossing the cell membrane and binding to intracellular glucocorticoid receptors (GR) in airway epithelial cells, macrophages, eosinophils, and lymphocytes. The activated GR-ICS complex translocates to the nucleus where it suppresses inflammatory gene transcription through two mechanisms: trans-repression (binding to NF-κB and AP-1 transcription factors, preventing their activation of pro-inflammatory cytokine genes including IL-4, IL-5, IL-13, TNF-α, and GM-CSF) and trans-activation (inducing anti-inflammatory proteins including lipocortin-1/annexin A1, which inhibits phospholipase A2 and thus blocks the entire arachidonic acid cascade). The net result is: reduced mucosal edema and microvascular permeability, decreased mucus hypersecretion, reduced eosinophilic infiltration and mast cell proliferation, restored beta-2 receptor responsiveness (preventing tachyphylaxis to beta-2 agonists), and decreased airway hyperresponsiveness (BHR).
ICS pharmacokinetics are influenced by the delivery device. Metered-dose inhalers (MDIs) deliver medication as an aerosol propelled by HFA (hydrofluoroalkane); only 10-20% reaches the lower airways while 60-80% deposits in the oropharynx (causing local side effects). Using a spacer/valved holding chamber with MDIs increases lower airway deposition to 20-40% and reduces oropharyngeal deposition by 90%, dramatically reducing local side effects. Dry powder inhalers (DPIs) are breath-actuated and require adequate inspiratory flow (>30-60 L/min depending on device); they may be less effective in patients with severe airflow limitation, young children, or elderly patients with weak inspiratory effort. Nebulized ICS (budesonide nebulization) is used for young children who cannot coordinate inhaler technique.